KENVUE INC (1KVUE.MI) Stock Price, Forecast & Analysis
Europe - BIT:1KVUE - US49177J1025 - Common Stock
1KVUE.MI Key Statistics, Chart & Performance
The current stock price of 1KVUE.MI is 14.39 EUR.
1KVUE.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| OR.PA | L'OREAL | 28.44 | 193.56B | ||
| LOR.DE | L'OREAL | 28.44 | 193.54B | ||
| UNA.AS | UNILEVER PLC | 23.44 | 128.72B | ||
| UNVB.DE | UNILEVER PLC | 23.49 | 129.02B | ||
| BEI.DE | BEIERSDORF AG | 23.22 | 22.25B | ||
| COTY.PA | COTY INC-CL A | 17.95 | 2.98B | ||
| ITP.PA | INTERPARFUMS SA | 16.3 | 2.39B | ||
| ICOS.MI | INTERCOS SPA | 24.08 | 1.14B | ||
| ONTEX.BR | ONTEX GROUP NV | 52.83 | 522.10M | ||
| PHN.MI | PHARMANUTRA SPA | 18.9 | 448.18M | ||
| ENV.MI | ENERVIT | 19.2 | 85.44M | ||
| JBOG.PA | JACQUES BOGART | N/A | 63.39M |
Related stock screener links
About 1KVUE.MI
Company Profile
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 22,000 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Company Info
KENVUE INC
1 Kenvue Way
Summit NEW JERSEY US
Employees: 22000
Phone: 19088741200
KENVUE INC / 1KVUE.MI FAQ
What does 1KVUE do?
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 22,000 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Can you provide the latest stock price for KENVUE INC?
The current stock price of 1KVUE.MI is 14.39 EUR. The price increased by 4.18% in the last trading session.
Does KENVUE INC pay dividends?
KENVUE INC (1KVUE.MI) has a dividend yield of 5.88%. The yearly dividend amount is currently 0.69.
What is the ChartMill rating of KENVUE INC stock?
1KVUE.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Should I buy 1KVUE stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1KVUE.MI.
Can you provide the market cap for KENVUE INC?
KENVUE INC (1KVUE.MI) has a market capitalization of 27.62B EUR. This makes 1KVUE.MI a Large Cap stock.
1KVUE.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1KVUE.MI.
1KVUE.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1KVUE.MI. There are concerns on the financial health of 1KVUE.MI while its profitability can be described as average.
1KVUE.MI Financial Highlights
Over the last trailing twelve months 1KVUE.MI reported a non-GAAP Earnings per Share(EPS) of 0.92. The EPS decreased by -12.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.37% | ||
| ROA | 5.23% | ||
| ROE | 13.22% | ||
| Debt/Equity | 0.73 |
1KVUE.MI Forecast & Estimates
For the next year, analysts expect an EPS growth of -7.42% and a revenue growth -2.77% for 1KVUE.MI